What is the Ownership and Shareholding Structure of Arene Life Sciences (Unit 3)?
In 2023, Arene Life Sciences (Unit 3) had a promoter holding of 73.71% and a public holding of 26.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX